Skip to main content
. Author manuscript; available in PMC: 2014 Aug 26.
Published in final edited form as: Arthritis Care Res (Hoboken). 2013 Dec;65(12):1942–1950. doi: 10.1002/acr.22093

Table 3.

Adjusted mean differences of baseline global T2 (ms) ±SEM and adjusted mean differences of T2 progression (ms) ±SEM for subjects with ≤2 metabolic factors (n=377) compared with subjects with ≥3 metabolic factors (n=26). P-values are from multivariate regression models adjusted for A: other OA risk factorsa, B: additionally adjusted for continuous BMI.

BASELINE T2 T2 PROGRESSION
Compartment A B A B
Global 2.0 (1.0; 2.9)
<0.001
1.2 (0.3, 2.1)
P=0.011
0.1 (−0.7; 0.9)
P=0.828
0.1 (−0.8; 0.9)
P=0.871
PAT 1.0 (−0.6; 2.6)
P=0.228
0.5 (−1.2; 2.2)
P=0.570
1.3 (−0.3; 2.9)
P=0.115
1.3 (−0.3 3.0)
P=0.112
MFC 1.4 (0.3; 2.4)
P=0.014
1.3 (0.1; 2.4)
P=0.029
0.0 (−1.0; 1.1)
P=925
0.3 (−0.8; 1.4)
P=0.578
LFC 0.9 (−0.1; 1.9)
P=0.076
0.9 (−0.2, 1.9)
P=0.105
0.6 (−0.4; 1.6)
P=0.256
0.5 (−0.5; 1.6)
P=0.308
MT 3.8 (2.5; 5.1)
P<0.001
2.4 (1.1; 3.6)
P<0.001
1.4 (0.1; 2.8)
P=0.040
0.7 (−0.7; 2.0)
P=0.354
LT 2.3 (0.9; 3.7)
P=0.001
0.6 (−0.7; 1.8)
P=0.387
0.1 (−1.0; 1.2)
P=0.843
0.1 (−1.0; 1.3)
P=0.813
a

All analyses include other OA risk factors as covariates: Herbeden’s nodes at the hands; family history of joint replacement; previous knee surgery; previous knee injury; age and gender. PAT, patella; MFC, medial femoral condyle; LFC, lateral femoral condyle; MT, medial tibia; LT, lateral tibia.